| Tradename: | AsthmaNefrin, Dey-Dose, Micronefrin, Nephron, S-2 Inhalant, Vaponefrin, Vaponephrin |
| Cas Number: | 329-65-7 |
| Pubchem: | 838 |
| Drugbank: | DB11124 |
| Chemspiderid: | 815 |
| Unii: | GR0L9S3J0F |
| Kegg: | D05688 |
| Chebi: | 194548 |
| Chembl: | 1740 |
| Synonyms: | Racepinephrine; Racemic epinephrine; Racemic adrenaline; DL-Epinephrine; DL-Adrenaline; dl-Epinephrine; dl-Adrenaline; (±)-Epinephrine; (±)-Adrenaline |
| Iupac Name: | 4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol |
| C: | 9 |
| H: | 13 |
| N: | 1 |
| O: | 3 |
| Smiles: | CNCC(C1=CC(=C(C=C1)O)O)O |
| Stdinchi: | 1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3 |
| Stdinchikey: | UCTWMZQNUQWSLP-UHFFFAOYSA-N |
Racepinefrine, or racepinephrine, sold under the brand name Vaponefrin among others, is a sympathomimetic medication described as a vasoconstrictor, bronchodilator, cardiostimulant, mydriatic, and antiglaucoma agent.[1] [2] [3] [4] [5] It is the racemic form of epinephrine (adrenaline) and is also known as dl-epinephrine and (±)-epinephrine. The drug is used pharmaceutically as the hydrochloride salt. It has been marketed in the United States and Canada.